PCI Commercial Packaging Brochure

The first-of-its-kind centre will offer biopharma clients convenience and efficiencies in the rapidly expanding Northeast

The move ensures the service provider has the capacity to meet the needs of an evolving clinical market

Pharmaceutical companies face continued pressure to develop and commercialize their medicines. PCI Clinical Services is committed to supporting clients at every stage of the clinical cycle, delivering best-in-class services efficiently and effectively.

The global outsourcing solutions provider is also set to expand its biotech capabilities in Europe.

Through the acquisition of Penn Pharma, PCI has significant experience in providing integrated drug development, clinical trial supply and commercial manufacturing of solid dose,liquid and semi-solid potent products to high standards of safety and quality.

PCI Pharma Services has bought Toronto-based packaging and labelling specialist Bellwyck Pharma Services, adding four GMP-compliant facilities in the US, Germany and Canada to its global network, the CDMO announced Tuesday.